Omnicell XT Amplify Launch Highlights Digital Health Role And Rich Valuation

Simply Wall St.01-25

Omnicell, ticker NasdaqGS:OMCL, has expanded its digital healthcare focus with new medication management solutions. The company has launched its XT Amplify program, aimed at supporting hospitals and ...

Source Link

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Comments

We need your insight to fill this gap

Leave a comment

{"i18n":{"language":"en_US"},"isChannel":false,"data":{"share":"https://ttm.financial/m/news/2606255116?lang=en_US&edition=fundamental","thumbnail":"https://images.simplywall.st/asset/industry/9551730-choice2-main-header/1585186975683","is_english":true,"pubTime":"2026-01-25 10:33","share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","id":"2606255116","market":"sg","top_or_hot":-1,"title":"Omnicell XT Amplify Launch Highlights Digital Health Role And Rich Valuation","media":"Simply Wall St.","content":"<div>\n<p>Omnicell, ticker NasdaqGS:OMCL, has expanded its digital healthcare focus with new medication management solutions. The company has launched its XT Amplify program, aimed at supporting hospitals and ...</p>\n\n<a href=\"https://simplywall.st/stocks/us/healthcare/nasdaq-omcl/omnicell/news/omnicell-xt-amplify-launch-highlights-digital-health-role-an\">Source Link</a>\n\n</div>\n","source":"simplywall_highlight","html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Omnicell XT Amplify Launch Highlights Digital Health Role And Rich Valuation</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nOmnicell XT Amplify Launch Highlights Digital Health Role And Rich Valuation\n</h2>\n\n<h4 class=\"meta\">\n\n\n2026-01-25 10:33 GMT+8&nbsp;&nbsp;&nbsp;<a href=https://simplywall.st/stocks/us/healthcare/nasdaq-omcl/omnicell/news/omnicell-xt-amplify-launch-highlights-digital-health-role-an><strong>Simply Wall St.</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>Omnicell, ticker NasdaqGS:OMCL, has expanded its digital healthcare focus with new medication management solutions. The company has launched its XT Amplify program, aimed at supporting hospitals and ...</p>\n\n<a href=\"https://simplywall.st/stocks/us/healthcare/nasdaq-omcl/omnicell/news/omnicell-xt-amplify-launch-highlights-digital-health-role-an\">Source Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"BK4167","symbol_name":"医疗保健技术","start_time":0,"source_url":"https://simplywall.st/stocks/us/healthcare/nasdaq-omcl/omnicell/news/omnicell-xt-amplify-launch-highlights-digital-health-role-an","article_id":"2606255116","we_media_id":null,"thumbnails":["https://images.simplywall.st/asset/industry/9551730-choice2-main-header/1585186975683"],"rights":{"source":"simplywall_highlight","url":"https://simplywall.st/stocks/us/healthcare/nasdaq-omcl/omnicell/news/omnicell-xt-amplify-launch-highlights-digital-health-role-an","rn_cache_url":null,"directOrigin":true},"url":"https://stock-news.laohu8.com/highlight/detail?id=2606255116","pubTimestamp":1769308401,"columns":[],"sourceInfo":{"source_id":"simplywall_highlight","name":"Simply Wall St."},"weMediaInfo":null,"summary":"Omnicell, ticker NasdaqGS:OMCL, has expanded its digital healthcare focus with new medication management solutions.\nThe company has launched its XT Amplify program, aimed at supporting hospitals and health systems with medication management.\nThese moves highlight Omnicell's efforts to align its portfolio with outcome focused digital healthcare trends.\n\nAt a share price of $50.3, Omnicell is coming off a mixed return profile, with the stock up 8.4% over the past 30 days and 11.4% year to...","collect":0,"end_time":0,"defaultTopTitle":"simplywall.st","property":[],"viewcount":null,"language":"en","relate_stocks":{"BK4167":"医疗保健技术","XT":"iShares Exponential Technologies ETF","BK4082":"医疗保健设备","OMCL":"Omnicell"},"translate_title":"Omnicell XT Amplify的推出凸显了数字健康的作用和丰富的估值","themeId":null,"isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"OMCL":1.5,"XT":1.5},"content_text":"Omnicell, ticker NasdaqGS:OMCL, has expanded its digital healthcare focus with new medication management solutions. The company has launched its XT Amplify program, aimed at supporting hospitals and health systems with medication management. These moves highlight Omnicell's efforts to align its portfolio with outcome focused digital healthcare trends.  At a share price of $50.3, Omnicell is coming off a mixed return profile, with the stock up 8.4% over the past 30 days and 11.4% year to date, while the 3 year and 5 year returns show declines of 12.6% and 57.3%. For investors tracking digital health exposure, NasdaqGS:OMCL sits in a part of the market that connects software, data and pharmacy operations. This can make company specific developments particularly important. The XT Amplify program and broader digital medication management push may influence how investors think about Omnicell's role in hospital workflows and pharmacy automation over time. For now, the key question is how effectively these offerings gain traction with health systems that are under pressure to improve safety, reduce waste and manage staffing constraints. Stay updated on the most important news stories for Omnicell by adding it to your watchlist or portfolio. Alternatively, explore our Community to discover new perspectives on Omnicell. NasdaqGS:OMCL Earnings & Revenue Growth as at Jan 2026 How Omnicell stacks up against its biggest competitors AdvertisementQuick Assessment  ✅ Price vs Analyst Target: At US$50.30, the price sits below the US$55.00 analyst target, with the low and high estimates at US$50.00 and US$63.00. ✅ Simply Wall St Valuation: The shares are described as trading close to estimated fair value, with a current P/E of 113.3 versus an industry average of 32.0. ✅ Recent Momentum: The stock has returned about 8.4% over the last 30 days.  Check out Simply Wall St's\nin-depth valuation analysis for Omnicell. Key Considerations  📊 XT Amplify and the wider digital medication management focus anchor Omnicell more firmly in software-enabled hospital workflows. 📊 Watch how recurring software revenue, hospital adoption metrics and any commentary on staffing or safety benefits track against this rollout. ⚠️ Execution on new offerings is important because the current P/E multiple of 113.3 already sits well above the Medical Equipment industry average of 32.0.  Dig Deeper For the full picture including more risks and rewards, check out the\ncomplete Omnicell analysis.  This article by Simply Wall St is general in nature. We provide commentary based on historical data\n    and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your\n    financial situation. We aim to bring you long-term focused analysis driven by fundamental data.\n    Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material.\n    Simply Wall St has no position in any stocks mentioned.New: AI Stock Screener & AlertsOur new AI Stock Screener scans the market every day to uncover opportunities.• Dividend Powerhouses (3%+ Yield)• Undervalued Small Caps with Insider Buying• High growth Tech and AI CompaniesOr build your own from over 50 metrics.Explore Now for FreeHave feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team@simplywallst.com","kind":"highlight","is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":null,"editions":null,"column":"","sentiment":"1","news_tag":"productRelease","news_rank":0,"symbols":[],"gpt_button":0,"need_auth":false,"code":"91000000","status":"200"},"commentList":[],"isCommentEnd":true,"newsSizeData":{"likeSize":0,"commentSize":0,"repostSize":0,"favoriteSize":0,"likeStatus":false,"favoriteStatus":false},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":true,"tenantId":"TBGLOBAL","deviceId":"web-server-community-laohu8-v3","version":"4.36.2","shortVersion":"4.36.2","platform":"web","vendor":"web","appName":"ttm","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"href":"/m/news/2606255116","isCrawlerRequest":true}